ETF Holdings Breakdown of DXCM

News associated with DXCM

Thursday's ETF Movers: KOKU, XSD

In trading on Thursday, the Xtrackers MSCI Kokusai Equity ETF (KOKU) is outperforming other ETFs, up about 9.6% on the day. Components of that ETF showing particular strength include shares of Dexcom (DXCM), up about 5.7% and shares of Newmont (NEM), up about 4.3% on the day. - 2025-04-10 15:02:29

O Shaughnessy Asset Management LLC Acquires 1,930 Shares of DexCom, Inc. (NASDAQ:DXCM)

O Shaughnessy Asset Management LLC raised its holdings in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 16.9% during the fourth quarter, according to its most recent filing with the SEC. The firm owned 13,384 shares of the medical device company’s stock after purchasing an additional 1,930 shares during the period. O Shaughnessy Asset […] - 2025-04-08 08:39:10

DexCom, Inc. (NASDAQ:DXCM) Given Consensus Recommendation of “Moderate Buy” by Analysts

DexCom, Inc. (NASDAQ:DXCM – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the eighteen ratings firms that are covering the firm, MarketBeat Ratings reports. Three investment analysts have rated the stock with a hold rating, thirteen have issued a buy rating and two have assigned a strong buy rating to […] - 2025-03-24 06:24:51

Independent Advisor Alliance Invests $244,000 in DexCom, Inc. (NASDAQ:DXCM)

Independent Advisor Alliance purchased a new position in DexCom, Inc. (NASDAQ:DXCM – Free Report) in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 3,135 shares of the medical device company’s stock, valued at approximately $244,000. Several other hedge funds and other institutional investors have also […] - 2025-03-20 08:24:48

Wealthfront Advisers LLC Sells 19,083 Shares of DexCom, Inc. (NASDAQ:DXCM)

Wealthfront Advisers LLC cut its position in DexCom, Inc. (NASDAQ:DXCM – Free Report) by 94.1% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,195 shares of the medical device company’s stock after selling 19,083 shares during the quarter. Wealthfront Advisers LLC’s holdings in […] - 2025-03-18 08:26:52

PNC Financial Services Group Inc. Has $3.63 Million Holdings in DexCom, Inc. (NASDAQ:DXCM)

PNC Financial Services Group Inc. raised its position in DexCom, Inc. (NASDAQ:DXCM – Free Report) by 21.5% in the fourth quarter, HoldingsChannel reports. The fund owned 46,669 shares of the medical device company’s stock after purchasing an additional 8,257 shares during the quarter. PNC Financial Services Group Inc.’s holdings in DexCom were worth $3,629,000 as […] - 2025-03-14 08:31:12

Head-To-Head Analysis: DexCom (NASDAQ:DXCM) and Biotricity (NASDAQ:BTCY)

Biotricity (NASDAQ:BTCY – Get Free Report) and DexCom (NASDAQ:DXCM – Get Free Report) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, analyst recommendations, valuation, profitability, dividends, institutional ownership and earnings. Institutional and Insider Ownership 3.9% of Biotricity shares are held […] - 2025-03-14 06:08:53

Atria Investments Inc Buys 2,059 Shares of DexCom, Inc. (NASDAQ:DXCM)

Atria Investments Inc grew its stake in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 13.4% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 17,379 shares of the medical device company’s stock after acquiring an additional 2,059 shares during the quarter. […] - 2025-03-12 11:27:45

Private Trust Co. NA Increases Stock Position in DexCom, Inc. (NASDAQ:DXCM)

Private Trust Co. NA lifted its holdings in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 266.3% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 337 shares of the medical device company’s stock after buying an additional 245 shares […] - 2025-03-07 09:43:01

Citigroup Issues Positive Forecast for DexCom (NASDAQ:DXCM) Stock Price

DexCom (NASDAQ:DXCM – Get Free Report) had its price target increased by equities researchers at Citigroup from $101.00 to $104.00 in a note issued to investors on Tuesday,Benzinga reports. The brokerage currently has a “buy” rating on the medical device company’s stock. Citigroup’s price target would indicate a potential upside of 26.89% from the company’s […] - 2025-03-06 08:37:44

Sanctuary Advisors LLC Acquires 3,226 Shares of DexCom, Inc. (NASDAQ:DXCM)

Sanctuary Advisors LLC grew its holdings in DexCom, Inc. (NASDAQ:DXCM – Free Report) by 21.7% during the 4th quarter, Holdings Channel reports. The firm owned 18,061 shares of the medical device company’s stock after purchasing an additional 3,226 shares during the period. Sanctuary Advisors LLC’s holdings in DexCom were worth $1,405,000 at the end of […] - 2025-02-26 08:50:49

NVIDIA's Rise Puts These 3 Healthcare Stocks in the Spotlight

ILMN, IQV and DXCM are leveraging AI advancements to drive innovation in genomics, clinical research and diabetes management. - 2025-02-18 17:35:00

Van ECK Associates Corp Has $6.67 Million Position in DexCom, Inc. (NASDAQ:DXCM)

Van ECK Associates Corp grew its stake in DexCom, Inc. (NASDAQ:DXCM – Free Report) by 325.0% during the 4th quarter, Holdings Channel.com reports. The firm owned 85,813 shares of the medical device company’s stock after acquiring an additional 65,622 shares during the period. Van ECK Associates Corp’s holdings in DexCom were worth $6,674,000 as of […] - 2025-02-18 08:36:52

DexCom, Inc. (NASDAQ:DXCM) Shares Sold by Kingsview Wealth Management LLC

Kingsview Wealth Management LLC cut its stake in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 45.0% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 2,819 shares of the medical device company’s stock after selling 2,303 shares during the […] - 2025-02-16 12:32:57

After-Hours Earnings Report for February 13, 2025 : AMAT, PANW, MSI, RSG, ABNB, COIN, DLR, AEM, IR, DXCM, GDDY, AEE

The following companies are expected to report earnings after hours on 02/13/2025. Visit our Earnings Calendar for a full list of expected earnings releases.Applied Materials, Inc. (AMAT)is reporting for the quarter ending January 31, 2025. The electric company company's consens - 2025-02-13 19:00:01

Bleakley Financial Group LLC Sells 322 Shares of DexCom, Inc. (NASDAQ:DXCM)

Bleakley Financial Group LLC lessened its position in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 6.1% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 4,968 shares of the medical device company’s stock after selling 322 shares during […] - 2025-02-11 08:54:53

Retirement Systems of Alabama Sells 2,184 Shares of DexCom, Inc. (NASDAQ:DXCM)

Retirement Systems of Alabama lowered its holdings in DexCom, Inc. (NASDAQ:DXCM – Free Report) by 2.5% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 84,567 shares of the medical device company’s stock after selling 2,184 shares during the period. Retirement Systems of Alabama’s holdings in DexCom were worth $6,577,000 at the end of […] - 2025-02-10 18:51:02

Caprock Group LLC Has $507,000 Position in DexCom, Inc. (NASDAQ:DXCM)

Caprock Group LLC grew its stake in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 86.0% in the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 6,515 shares of the medical device company’s stock after buying an additional 3,012 shares during the period. Caprock Group LLC’s holdings in […] - 2025-02-05 08:57:35

DexCom (NASDAQ:DXCM) Upgraded at Redburn Atlantic

Redburn Atlantic upgraded shares of DexCom (NASDAQ:DXCM – Free Report) from a neutral rating to a buy rating in a research report sent to investors on Monday morning, MarketBeat reports. The firm currently has $115.00 price objective on the medical device company’s stock, up from their previous price objective of $85.00. A number of other […] - 2025-02-04 08:41:12

Prediction: This Top Growth Stock Will Outperform the Market in the Next Decade

Medical device specialist DexCom (NASDAQ: DXCM) has substantially underperformed the market over the trailing-12-month period. The diabetes-focused company disappointed investors last year due to unimpressive financial results, especially in the second and third quarters. - 2025-02-03 14:15:00

DXCM institutional holdings

Fatal error: Uncaught mysqli_sql_exception: Column 'Currency_Code' in field list is ambiguous in /var/www/liquidata/show_aggregate_holdings.php:119 Stack trace: #0 /var/www/liquidata/show_aggregate_holdings.php(119): mysqli->query() #1 {main} thrown in /var/www/liquidata/show_aggregate_holdings.php on line 119

Date	ETF ISIN/Name	Num Shares	Book value